All Stories

  1. Data from Ubiquitination of Oncogenic Mutant p53 via Attenuation of Ribosome Biogenesis Machinery Effectively Inhibits Pancreatic Tumor Growth

    Article • June 2026, American Association for Cancer Research (AACR)

    Dr. Sahir Sultan Alvi

  2. Supplementary Data 1 from Ubiquitination of Oncogenic Mutant p53 via Attenuation of Ribosome Biogenesis Machinery Effectively Inhibits Pancreatic Tumor Growth

    Article • June 2026, American Association for Cancer Research (AACR)

    Dr. Sahir Sultan Alvi

  3. Supplementary Figure 1 from Ubiquitination of Oncogenic Mutant p53 via Attenuation of Ribosome Biogenesis Machinery Effectively Inhibits Pancreatic Tumor Growth

    Article • June 2026, American Association for Cancer Research (AACR)

    Dr. Sahir Sultan Alvi

  4. Supplementary Figure 2 from Ubiquitination of Oncogenic Mutant p53 via Attenuation of Ribosome Biogenesis Machinery Effectively Inhibits Pancreatic Tumor Growth

    Article • June 2026, American Association for Cancer Research (AACR)

    Dr. Sahir Sultan Alvi

  5. Supplementary Figure 3 from Ubiquitination of Oncogenic Mutant p53 via Attenuation of Ribosome Biogenesis Machinery Effectively Inhibits Pancreatic Tumor Growth

    Article • June 2026, American Association for Cancer Research (AACR)

    Dr. Sahir Sultan Alvi

  6. Supplementary Figure 4 from Ubiquitination of Oncogenic Mutant p53 via Attenuation of Ribosome Biogenesis Machinery Effectively Inhibits Pancreatic Tumor Growth

    Article • June 2026, American Association for Cancer Research (AACR)

    Dr. Sahir Sultan Alvi

  7. Supplementary Figure 5 from Ubiquitination of Oncogenic Mutant p53 via Attenuation of Ribosome Biogenesis Machinery Effectively Inhibits Pancreatic Tumor Growth

    Article • June 2026, American Association for Cancer Research (AACR)

    Dr. Sahir Sultan Alvi

  8. Supplementary Figure 6 from Ubiquitination of Oncogenic Mutant p53 via Attenuation of Ribosome Biogenesis Machinery Effectively Inhibits Pancreatic Tumor Growth

    Article • June 2026, American Association for Cancer Research (AACR)

    Dr. Sahir Sultan Alvi

  9. Supplementary Figure 7 from Ubiquitination of Oncogenic Mutant p53 via Attenuation of Ribosome Biogenesis Machinery Effectively Inhibits Pancreatic Tumor Growth

    Article • June 2026, American Association for Cancer Research (AACR)

    Dr. Sahir Sultan Alvi

  10. Supplementary Figure 8 from Ubiquitination of Oncogenic Mutant p53 via Attenuation of Ribosome Biogenesis Machinery Effectively Inhibits Pancreatic Tumor Growth

    Article • June 2026, American Association for Cancer Research (AACR)

    Dr. Sahir Sultan Alvi

  11. Supplementary Figure 9 from Ubiquitination of Oncogenic Mutant p53 via Attenuation of Ribosome Biogenesis Machinery Effectively Inhibits Pancreatic Tumor Growth

    Article • June 2026, American Association for Cancer Research (AACR)

    Dr. Sahir Sultan Alvi

  12. Supplementary Tables from Ubiquitination of Oncogenic Mutant p53 via Attenuation of Ribosome Biogenesis Machinery Effectively Inhibits Pancreatic Tumor Growth

    Article • June 2026, American Association for Cancer Research (AACR)

    Dr. Sahir Sultan Alvi

  13. Diallyl trisulfide attenuates metabolic syndrome via integrated modulation of PCSK-9/LDL-R axis, redox homeostasis, and inflammatory cytokine networks in high-carbohydrate high-fat (HCHF) diet-fed rats

    Article • Frontiers in Pharmacology, May 2026, Frontiers

    Dr. Sahir Sultan Alvi

  14. Prognostic significance and interplay of circulatory PCSK-9–ApoCIII–chemokine axis in type 2 diabetes and its complications: a pilot study in North Indian patients

    Article • The Egyptian Journal of Internal Medicine, April 2026, Springer Science + Business Media

    Dr. Sahir Sultan Alvi

  15. Repurposing of FDA-approved Drugs Identifies Glipizide as a Potent HMG-CoA Reductase Inhibitor: a High-Throughput Virtual Screening and Molecular Dynamics Approach for Targeting Hypercholesterolemia

    Article • Journal of Pharmaceutical Innovation, January 2026, Springer Science + Business Media

    Dr. Sahir Sultan Alvi

  16. Ubiquitination of mut-p53 Inhibits Pancreatic Tumor Growth

    Article • Molecular Cancer Therapeutics, November 2025, American Association for Cancer Research (AACR)

    Dr. Sahir Sultan Alvi

  17. Anti-breast cancer potential of fluoro-containing triazole-synthesized hybrid molecules: In-vitro screening and Force Field-based molecular dynamics approach

    Article • Next Research, September 2025, Elsevier

    Dr. Sahir Sultan Alvi, Mohd Asif

  18. Mitochondrial ribosomal protein L3 (MRPL3): An early diagnostic biomarker and potential molecular target in pancreatic cancer

    Article • Translational Oncology, August 2025, Elsevier

    Dr. Sahir Sultan Alvi

  19. Honey Targets Ribosome Biogenesis Components to Suppress the Growth of Human Pancreatic Cancer Cells

    Article • Cancers, October 2024, MDPI AG

    Dr. Sahir Sultan Alvi

  20. Medicinal significance of sp2/sp3 hybridized at C-3-substituted indole-containing lead molecules and FDA-approved drugs

    Article • Medicinal Chemistry Research, September 2024, Springer Science + Business Media

    Dr. Sahir Sultan Alvi, Mohd Asif

  21. Organosulfur Compounds, S‐Allyl‐L‐Cysteine and S‐Ethyl‐L‐Cysteine, Target PCSK‐9/LDL‐R‐Axis to Ameliorate Cardiovascular, Hepatic, and Metabolic Changes in High Carbohydrate and High Fat Diet‐Induced Metabolic Syndro...

    Article • Phytotherapy Research, September 2024, Wiley

    Dr. Sahir Sultan Alvi

  22. Targeting SARS-CoV-2 main protease (Mpro) and human ACE-2: A virtual screening of carotenoids and polyphenols from tomato (Solanum lycopersicum L.) to combat Covid-19

    Article • Intelligent Pharmacy, February 2024, Elsevier

    Dr. Sahir Sultan Alvi

  23. Association of PCSK-9 with the Biomarkers of Type-2 Diabetes and its Complications in the Indian Population: a Pilot Study

    Article • Clinical Laboratory, January 2024, Clinical Laboratory Publications

    Dr. Sahir Sultan Alvi

  24. Assessment of the mechanical and durability characteristics of bio-mineralized Bacillus subtilis self-healing concrete blended with hydrated lime and brick powder

    Article • Case Studies in Construction Materials, December 2023, Elsevier

    Dr. Sahir Sultan Alvi

  25. Naturally occurring organosulfur compounds effectively inhibits PCSK-9 activity and restrict PCSK-9-LDL-receptor interaction via in-silico and in-vitro approach

    Article • Natural Product Research, October 2023, Taylor & Francis

    Dr. Sahir Sultan Alvi

  26. Novel Functionalized Spiro [Indoline-3,5′-pyrroline]-2,2′dione Derivatives: Synthesis, Characterization, Drug-Likeness, ADME, and Anticancer Potential

    Article • International Journal of Molecular Sciences, April 2023, MDPI AG

    Mohd Asif , Dr. Sahir Sultan Alvi

  27. Abstract 4427: Cucurbitacin B: A promising drug candidate for targeting tumor immunosuppressive cells

    Article • Cancer Research, April 2023, American Association for Cancer Research (AACR)

    Dr. Sahir Sultan Alvi

  28. Association of circulatory PCSK-9 with biomarkers of redox imbalance and inflammatory cascades in the prognosis of diabetes and associated complications: a pilot study in the Indian population

    Article • Free Radical Research, April 2023, Taylor & Francis

    Dr. Sahir Sultan Alvi

  29. Triphala extract for the treatment of gastric ulcers and oxidative stress in rats.

    Article • January 2023, Indian Pharmaceutical Association - IPA

    Dr. Sahir Sultan Alvi

  30. Berberis aristata and its secondary metabolites: Insights into nutraceutical and therapeutical applications

    Article • Pharmacological Research - Modern Chinese Medicine, December 2022, Elsevier

    Dr. Sahir Sultan Alvi

  31. Target-Based Virtual and Biochemical Screening Against HMG-CoA Reductase Reveals Allium sativum-Derived Organosulfur Compound N-Acetyl Cysteine as a Cardioprotective Agent

    Article • Revista Brasileira de Farmacognosia, October 2022, Springer Science + Business Media

    Dr. Sahir Sultan Alvi

  32. Carvacrol protects against carbonyl osmolyte-induced structural modifications and aggregation to serum albumin: Insights from physicochemical and molecular interaction studies

    Article • International Journal of Biological Macromolecules, July 2022, Elsevier

    Dr. Sahir Sultan Alvi

  33. Correction to: Identification and evaluation of natural organosulfur compounds as potential dual inhibitors of α-amylase and α-glucosidase activity: an in-silico and in-vitro approach

    Article • Medicinal Chemistry Research, October 2021, Springer Science + Business Media

    Dr. Sahir Sultan Alvi

  34. Identification and evaluation of natural organosulfur compounds as potential dual inhibitors of α-amylase and α-glucosidase activity: an in-silico and in-vitro approach

    Article • Medicinal Chemistry Research, September 2021, Springer Science + Business Media

    Dr. Sahir Sultan Alvi

  35. Ezetimibe attenuates experimental diabetes and renal pathologies via targeting the advanced glycation, oxidative stress and AGE-RAGE signalling in rats

    Article • Archives of Physiology and Biochemistry, January 2021, Taylor & Francis

    Dr. Sahir Sultan Alvi

  36. Glycyrrhizic Acid Scavenges Reactive Carbonyl Species and Attenuates Glycation‐Induced Multiple Protein Modification: An In Vitro and In Silico Study

    Article • Oxidative Medicine and Cellular Longevity, January 2021, Wiley

    Dr. Sahir Sultan Alvi

  37. Amelioration of neuropilin-1 and RAGE/matrix metalloproteinase-2 pathway-induced renal injury in diabetic rats by rosuvastatin

    Article • Archives of Biological Sciences, January 2021, National Library of Serbia

    Dr. Sahir Sultan Alvi

  38. Insights into pharmacological mechanisms of polydatin in targeting risk factors-mediated atherosclerosis

    Article • Life Sciences, August 2020, Elsevier

    Dr. Sahir Sultan Alvi

  39. A biochemical & biophysical study on in-vitro anti-glycating potential of iridin against d-Ribose modified BSA

    Article • Archives of Biochemistry and Biophysics, June 2020, Elsevier

    Dr. Sahir Sultan Alvi

  40. Phyllanthus virgatus forst against oxidative stress and retino-nephropathy in diabetic rats

    Article • Pakistan Journal of Pharmaceutical Sciences, November 2019, Faculty of Pharmacy and Pharmaceutical Sciences, University of Karachi

    Dr. Sahir Sultan Alvi

  41. Modulatory role of HMG-CoA reductase inhibitors and ezetimibe on LDL-AGEs-induced ROS generation and RAGE-associated signalling in HEK-293 Cells

    Article • Life Sciences, October 2019, Elsevier

    Dr. Sahir Sultan Alvi

  42. Therapeutic efficacy of Boerhaavia diffusa (Linn.) root methanolic extract in attenuating streptozotocin-induced diabetes, diabetes-linked hyperlipidemia and oxidative-stress in rats

    Article • Biomedical Research and Therapy, July 2019, Biomedical Research and Therapy

    Dr. Sahir Sultan Alvi

  43. Ginkgolide B Mediated Alleviation of Inflammatory Cascades and Altered Lipid Metabolism in HUVECs via Targeting PCSK-9 Expression and Functionality

    Article • BioMed Research International, June 2019, Hindawi Publishing Corporation

    Dr. Sahir Sultan Alvi

  44. Glycation and HMG-CoA Reductase Inhibitors: Implication in Diabetes and Associated Complications

    Article • Current Diabetes Reviews, April 2019, Bentham Science Publishers

    Dr. Sahir Sultan Alvi, Saheem Ahmad

  45. Natural organosulfur compounds and cardiovascular diseases

    Article • January 2019, Springer Science + Business Media

    Dr. Sahir Sultan Alvi

  46. Rosemary and neurological disorders.

    Article • January 2019, Springer Science + Business Media

    Dr. Sahir Sultan Alvi

  47. Antiglycation study of HMG-R inhibitors and tocotrienol against glycated BSA and LDL: A comparative study

    Article • International Journal of Biological Macromolecules, September 2018, Elsevier

    Dr. Sahir Sultan Alvi, Professor Rizwan Hasan Khan

  48. Lycopene amends LPS induced oxidative stress and hypertriglyceridemia via modulating PCSK-9 expression and Apo-CIII mediated lipoprotein lipase activity

    Article • Biomedicine & Pharmacotherapy, December 2017, Elsevier

    Sahir Sultan Alvi, Dr. Sahir Sultan Alvi

  49. Potential role of lycopene in targeting proprotein convertase subtilisin/kexin type-9 to combat hypercholesterolemia

    Article • Free Radical Biology and Medicine, July 2017, Elsevier

    IRFAN ANSARI, Sahir Sultan Alvi, Dr. Sahir Sultan Alvi

  50. Molecular rationale delineating the role of lycopene as a potent HMG-CoA reductase inhibitor:in vitroandin silicostudy

    Article • Natural Product Research, November 2015, Taylor & Francis

    Sahir Sultan Alvi, Dr. Sahir Sultan Alvi